JARID1D-dependent androgen receptor and JunD signaling activation of osteoclast differentiation inhibits prostate cancer bone metastasis through demethylating H3K4
Year: 2024
Type: article
Abstract: These insights provide a theoretical foundation for targeting JARID1D and related molecules in the treatment of PCa bone metastasis.
Source: Theranostics
DOI: 10.7150/thno.104135
Authors: Yaohua Hu, Zhite Zhao, Qinghua Xie, Hui Li, Chenyang Zhang, Xinglin He, Yifan Ma, Caiqin Zhang, Qinlong Li, Changhong Shi
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,671
OpenAlex ID: W4405953770